Expense Ratio Rating
3 /10
Expense Rating
0 /10
Market Score
8 /10
Category Score
8 /10
Market Size
8 /10
$AIIEX Alternatives
Different Funds
We found 9,394 International Stocks Large Growth funds. Here they are ordered by FI Score.
- btal
- ETF
- Alternatives
- Neutral
AGFiQ U.S. Market Neutral Anti-Beta Fund
Expenses: 2.11% (Better than 0% of similar funds)
This is a bad choice for a Neutral Alternatives fund. See why »
- ryucx
- Mutual Fund
- Alternatives
- Inverse
Rydex Inverse S&P 500® Strategy Fund Class C
Expenses: 2.51% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternatives fund. See why »
- evgbc
- ETF
- Allocation
- Total World
Eaton Vance Global Income Builder NextShares
Expenses: 0.85% (Better than 1% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- fbdix
- Mutual Fund
- Sector Equity
- Healthcare
Franklin Biotechnology Discovery Fund Class A
Expenses: 1.00% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »
- gprox
- Mutual Fund
- Allocation
- Total World
Grandeur Peak Global Reach Fund Investor Class
Expenses: 1.52% (Better than 0% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- sfltx
- Mutual Fund
- Bond
- Municipal Bond
Virtus Seix High Grade Municipal Bond Fund Class A
Expenses: 0.75% (Better than 1% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
- hfcsx
- Mutual Fund
- US Stocks
- Mid-Cap Growth
Hennessy Focus Fund Investor Class
Expenses: 1.47% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »
- figix
- Mutual Fund
- Bond
- Government Bond
Federated U.S. Government Securities Fund 2-5 Year Service Shares
Expenses: 0.82% (Better than 0% of similar funds)
This is a bad choice for a Government Bond Bond fund. See why »
- hghtx
- Mutual Fund
- Sector Equity
- Healthcare
The Hartford Healthcare Fund Class R5
Expenses: 1.02% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »